- Home
- SAGE vs LASR Comparison
SAGE vs LASR Comparison
Compare SAGE & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- LASR
- Stock Information
- Founded
- SAGE 2010
- LASR 2000
- Country
- SAGE United States
- LASR United States
- Employees
- SAGE N/A
- LASR N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- LASR Semiconductors
- Sector
- SAGE Health Care
- LASR Technology
- Exchange
- SAGE Nasdaq
- LASR Nasdaq
- Market Cap
- SAGE 415.0M
- LASR N/A
- IPO Year
- SAGE 2014
- LASR 2018
- Fundamental
- Price
- SAGE $6.71
- LASR $8.61
- Analyst Decision
- SAGE Hold
- LASR Strong Buy
- Analyst Count
- SAGE 19
- LASR 4
- Target Price
- SAGE $9.88
- LASR $15.13
- AVG Volume (30 Days)
- SAGE 934.8K
- LASR 268.3K
- Earning Date
- SAGE 04-29-2025
- LASR 05-08-2025
- Dividend Yield
- SAGE N/A
- LASR N/A
- EPS Growth
- SAGE N/A
- LASR N/A
- EPS
- SAGE N/A
- LASR N/A
- Revenue
- SAGE $47,404,000.00
- LASR $198,548,000.00
- Revenue This Year
- SAGE $100.64
- LASR $8.26
- Revenue Next Year
- SAGE $70.19
- LASR $10.40
- P/E Ratio
- SAGE N/A
- LASR N/A
- Revenue Growth
- SAGE N/A
- LASR N/A
- 52 Week Low
- SAGE $4.62
- LASR $6.20
- 52 Week High
- SAGE $14.56
- LASR $14.73
- Technical
- Relative Strength Index (RSI)
- SAGE 35.06
- LASR 60.32
- Support Level
- SAGE $7.23
- LASR $7.88
- Resistance Level
- SAGE $7.63
- LASR $8.60
- Average True Range (ATR)
- SAGE 0.29
- LASR 0.33
- MACD
- SAGE -0.09
- LASR 0.16
- Stochastic Oscillator
- SAGE 0.38
- LASR 97.38
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.